Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 2/2004

01-02-2004

Adaptive Cytoprotection Induced by Pretreatment with Ethanol Protects Against Gastric Cell Damage by NSAIDs

Authors: Ken-Ichiro Tanaka, Kiyo Nishimoto, Wataru Tomisato, Shinji Tsutsumi, Tatsuya Hoshino, Tomofusa Tsuchiya, Tohru Mizushima

Published in: Digestive Diseases and Sciences | Issue 2/2004

Login to get access
Metadata
Title
Adaptive Cytoprotection Induced by Pretreatment with Ethanol Protects Against Gastric Cell Damage by NSAIDs
Authors
Ken-Ichiro Tanaka
Kiyo Nishimoto
Wataru Tomisato
Shinji Tsutsumi
Tatsuya Hoshino
Tomofusa Tsuchiya
Tohru Mizushima
Publication date
01-02-2004
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 2/2004
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/B:DDAS.0000017440.46863.56

Other articles of this Issue 2/2004

Digestive Diseases and Sciences 2/2004 Go to the issue

ReviewPaper

CASE REPORT: Prolonged Remission of Severe Crohn's Disease After Fever and Leukopenia Caused by 6-Mercaptopurine

OriginalPaper

Effect of Acute Self-Limited Hepatitis C Virus (HCV) Superinfection on Hepatitis B Virus (HBV)-Related Cirrhosis. Virological Features of HBV–HCV Dual Infection

OriginalPaper

Do Cholecystokinin Antagonists Increase Cytosolic Calcium in Pancreatic Acinar Cells and Thereby Promote Pancreatitis?

OriginalPaper

Ethnic Differences in the Prevalence of Endoscopic Esophagitis and Barrett's Esophagus: The Long and Short of It All

OriginalPaper

Relationship Between Hiatal Hernia and Inguinal Hernia

OriginalPaper

CASE REPORT: Omental Mass Secondary to Metastatic Breast Cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits